FAP and neoplasm: In contrast to its high tumor retention in xenograft tissues and in patients [16, 22], FAP-2286 is not ideally suited for targeting FAP in syngeneic mouse models due to its substantial lower affinity towards murine FAP (KD = 3.8 ± 1.0 nM) [16].